Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma ; volume:43 ; number:1 ; day:22 ; month:10 ; year:2024 ; pages:1-18 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (22.10.2024), 1-18, 12.2024
- Creator
-
Tempora, Patrizia
D’Amico, Silvia
Gragera, Paula
Damiani, Verena
Krol, Kamila
Scaldaferri, Valentina
Pandey, Kirti
Chung, Shanzou
Lucarini, Valeria
Giorda, Ezio
Scarsella, Marco
Volpe, Gabriele
Pezzullo, Marco
De Stefanis, Cristiano
D’Oria, Valentina
De Angelis, Lorenzo
Giovannoni, Roberto
De Ioris, Maria Antonietta
Melaiu, Ombretta
Purcell, Anthony W.
Locatelli, Franco
Fruci, Doriana
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-024-03180-y
- URN
-
urn:nbn:de:101:1-2501102101008.380543881741
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tempora, Patrizia
- D’Amico, Silvia
- Gragera, Paula
- Damiani, Verena
- Krol, Kamila
- Scaldaferri, Valentina
- Pandey, Kirti
- Chung, Shanzou
- Lucarini, Valeria
- Giorda, Ezio
- Scarsella, Marco
- Volpe, Gabriele
- Pezzullo, Marco
- De Stefanis, Cristiano
- D’Oria, Valentina
- De Angelis, Lorenzo
- Giovannoni, Roberto
- De Ioris, Maria Antonietta
- Melaiu, Ombretta
- Purcell, Anthony W.
- Locatelli, Franco
- Fruci, Doriana
- SpringerLink (Online service)
Other Objects (12)
Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy
What the missionaries have to overcome
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Silencing of Nicotiana benthamiana Neuroblastoma-Amplified Genecauses ER stress and cell death
Immunotherapy for neuroblastoma elicits a complement dependent whole body allodynia
A CIN ful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
Novel strategies to overcome chemoresistance in glioblastoma
Japan: How to Overcome the Difficult Decade?
How companies overcome barriers to overseas business
Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy
What the missionaries have to overcome
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Silencing of Nicotiana benthamiana Neuroblastoma-Amplified Genecauses ER stress and cell death
Immunotherapy for neuroblastoma elicits a complement dependent whole body allodynia
A CIN ful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
Novel strategies to overcome chemoresistance in glioblastoma
Japan: How to Overcome the Difficult Decade?
How companies overcome barriers to overseas business
Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy
What the missionaries have to overcome
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Silencing of Nicotiana benthamiana Neuroblastoma-Amplified Genecauses ER stress and cell death
Immunotherapy for neuroblastoma elicits a complement dependent whole body allodynia
A CIN ful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
Novel strategies to overcome chemoresistance in glioblastoma
Japan: How to Overcome the Difficult Decade?